α1-adrenoceptors:: Subtypes, signaling, and roles in health and disease

被引:80
作者
García-Sáinz, JA
Vázquez-Prado, J
Villalobos-Molina, R
机构
[1] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular, Mexico City 04510, DF, Mexico
[2] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Farmacol & Toxicol, Mexico City, DF, Mexico
关键词
alpha(1)-adrenoceptors; alpha(1)-adrenergic receptors; G proteins; signaling;
D O I
10.1016/S0188-0128(99)00059-7
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
alpha(1)-adrenoceptors mediate some of the main actions of the natural catecholamines, adrenaline, and noradrenaline. They participate in many essential physiological processes, such as sympathetic neurotransmission, modulation of hepatic metabolism, control of vascular tone, cardiac contraction, and the regulation of smooth muscle activity in the genitourinary system. It is now clear that alpha(1)-adrenoceptors mediate, in addition to immediate effects, longer term actions of catecholamines such as cell growth and proliferation. In fact, adrenoceptor genes can be considered as protooncogenes. Over the past years, considerable progress has been achieved in the molecular characterization of different alpha(1)-adrenoceptor subtypes. Three main subtypes have been characterized pharmacologically and in molecular terms. Splice variants, truncated isoforms, and polymorphisms have also been detected. Similarly, it is now clear that these receptors are coupled to several classes of G proteins that, therefore, are capable of modulating different signaling pathways. In the present article, some of these aspects are reviewed, together with the distribution of the subtypes in different tissues and some of the known roles of these receptors in health and disease. (C) 2000 IMSS. Published by Elsevier Science Inc.
引用
收藏
页码:449 / 458
页数:10
相关论文
共 119 条
  • [51] Structural and functional aspects of G protein-coupled receptor oligomerization
    Hébert, TE
    Bouvier, M
    [J]. BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 1998, 76 (01): : 1 - 11
  • [52] HIEBLE JP, 1995, PHARMACOL REV, V47, P267
  • [53] The use of alpha-adrenoceptor antagonists in the pharmacological management of benign prostatic hypertrophy: An overview
    Hieble, JP
    Ruffolo, RR
    [J]. PHARMACOLOGICAL RESEARCH, 1996, 33 (03) : 145 - 160
  • [54] CLONING, FUNCTIONAL EXPRESSION AND TISSUE DISTRIBUTION OF HUMAN ALPHA(1C)-ADRENOCEPTOR SPLICE VARIANTS
    HIRASAWA, A
    SHIBATA, K
    HORIE, K
    TAKEI, Y
    OBIKA, K
    TANAKA, T
    MURAMOTO, N
    TAKAGAKI, K
    YANO, J
    TSUJIMOTO, G
    [J]. FEBS LETTERS, 1995, 363 (03) : 256 - 260
  • [55] HORIE K, 1995, MOL PHARMACOL, V48, P392
  • [56] CROSSTALK - A PIVOTAL ROLE FOR PROTEIN-KINASE-C IN MODULATING RELATIONSHIPS BETWEEN SIGNAL TRANSDUCTION PATHWAYS
    HOUSLAY, MD
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1991, 195 (01): : 9 - 27
  • [57] alpha(1) Adrenergic receptors activate phosphatidylinositol 3-kinase in human vascular smooth muscle cells - Role in mitogenesis
    Hu, ZW
    Shi, XY
    Lin, RZ
    Hoffman, BB
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (15) : 8977 - 8982
  • [58] Contrasting signaling pathways of α1A- and α1B-adrenergic receptor subtype activation of phosphatidylinositol 3-kinase and Ras in transfected NIH3T3 cells
    Hu, ZW
    Shi, XY
    Lin, RZ
    Hoffman, BB
    [J]. MOLECULAR ENDOCRINOLOGY, 1999, 13 (01) : 3 - 14
  • [59] Evidence for an age-dependent functional expression of alpha(1D)-adrenoceptors in the rat vasculature
    Ibarra, M
    Terron, JA
    LopezGuerrero, JJ
    VillalobosMolina, R
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 322 (2-3) : 221 - 224
  • [60] IBARRA M, 1998, PHARM REV COMMUN, V10, P135